保健医学研究与实践2024，Vol.21Issue(1)：150-156,7.DOI:10.11986/j.issn.1673-873X.2024.01.25
合并微血管侵犯的HCC患者术后辅助治疗:现状与前景
Postoperative adjuvant therapy for HCC patients with microvascular invasion:current status and prospects
摘要
Abstract
Primary hepatocellular carcinoma is a common malignant tumor worldwide,and surgical resection remains the first choice of treatment.However,microvascular invasion(MVI)as an independent risk factor affects the survival of pa-tients after surgery.This article introduces the effect of postoperative MVI positive on prognoses and reviews several adju-vant therapy methods commonly used to prevent postoperative recurrence and improve the survival of patients undergoing hepatectomy,including radiotherapy,transcatheter arterial chemoembolization(TACE),hepatic arterial infusion chemo-therapy(HAIC),targeted therapy,immunotherapy,antiviral,and nutritional support therapy.The therapeutic effects of various therapies on MVI positive patients were reviewed.Here,we concluded that most treatments have shown promise,but efficacy and target populations need to be further explored,combined therapy may be the direction of postoperative adju-vant therapy in the future.关键词
原发性肝癌/微血管侵犯/肿瘤复发/术后辅助治疗Key words
Primary liver cancer/Microvascular invasion/Tumor recurrence/Postoperative adjuvant therapy分类
医药卫生引用本文复制引用
黄俊杰,黄平,廖锐,孙锐睿,曹洪祥..合并微血管侵犯的HCC患者术后辅助治疗:现状与前景[J].保健医学研究与实践,2024,21(1):150-156,7.基金项目
重庆市自然科学基金(CSTB2022NSCQ-MSX0112). （CSTB2022NSCQ-MSX0112）
